104,328 Shares in Teleflex Incorporated $TFX Acquired by Legal & General Group Plc

Legal & General Group Plc acquired a new stake in Teleflex Incorporated (NYSE:TFX) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 104,328 shares of the medical technology company’s stock, valued at approximately $13,225,000. Legal & General Group Plc owned about 0.25% of Teleflex at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in TFX. BlackRock Inc. acquired a new stake in shares of Teleflex in the 2nd quarter valued at $688,537,000. Janus Henderson Group PLC boosted its stake in Teleflex by 1.1% in the first quarter. Janus Henderson Group PLC now owns 4,291,311 shares of the medical technology company’s stock valued at $513,281,000 after buying an additional 45,199 shares in the last quarter. AQR Capital Management LLC boosted its stake in Teleflex by 478.1% in the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock valued at $287,603,000 after buying an additional 1,956,811 shares in the last quarter. State Street Corp raised its stake in Teleflex by 1.5% during the fourth quarter. State Street Corp now owns 1,478,776 shares of the medical technology company’s stock worth $180,470,000 after acquiring an additional 22,111 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in Teleflex by 0.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,250,665 shares of the medical technology company’s stock worth $152,630,000 after acquiring an additional 5,051 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Price Performance

Shares of NYSE:TFX opened at $139.81 on Monday. The firm has a market cap of $5.92 billion, a PE ratio of -6.00, a price-to-earnings-growth ratio of 0.93 and a beta of 0.81. The firm’s fifty day moving average is $133.86 and its 200-day moving average is $126.05. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.12 and a current ratio of 2.60. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $145.00.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, August 6th. The medical technology company reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.48. The company had revenue of $570.33 million for the quarter, compared to analysts’ expectations of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. Teleflex’s revenue for the quarter was up 28.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.73 earnings per share. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Sell-side analysts predict that Teleflex Incorporated will post 7.26 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Friday, August 14th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s dividend payout ratio is presently -5.84%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Mizuho upped their price objective on shares of Teleflex from $140.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 15th. Royal Bank Of Canada upgraded shares of Teleflex from a “sector perform” rating to an “outperform” rating and upped their price target for the stock from $135.00 to $155.00 in a report on Friday, May 8th. Wells Fargo & Company increased their price target on Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a research note on Friday, May 8th. BMO Capital Markets started coverage on Teleflex in a report on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price objective on the stock. Finally, Truist Financial boosted their price objective on Teleflex from $143.00 to $150.00 and gave the stock a “hold” rating in a research report on Monday, August 10th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Teleflex presently has an average rating of “Hold” and an average target price of $152.90.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.